Merck KGaA | 102.50 / -0.29% |
Date/Time | 12/13 / 17:29 |
Chg. / Chg.(%) | -0.30 / -0.29% |
Bid | 102.05 / 175 |
Ask | 104.70 / 173 |
Open | 103.50 |
Previous Close | 102.80 |
High | 103.75 |
Low | 102.10 |
Volume [EUR] | 7,297,112.73 |
Volume [Units] | 70,945 |
Price fixings | 1205 |
ISIN | DE0006599905 |
Security | MRK/D |
Exchange | Cboe Europe BXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 102.500 | ||
Xetra | 102.70 | ![]() |
543,621 |
Cboe Europe .. | 102.50 | ![]() |
179,725 |
London Inter.. | 102.40 | ![]() |
126,146 |
Turquoise | 102.50 | ![]() |
81,074 |
Cboe Europe .. | 102.50 | ![]() |
70,945 |
Stuttgart | 102.600 | ![]() |
4,330 |
TradeGate | 103.100 | ![]() |
3,978 |
München | 103.00 | ![]() |
950 |
Hamburg | 102.65 | ![]() |
520 |
Borsa Italia.. | 103.30 | ![]() |
200 |
Frankfurt | 104.4000 | ![]() |
150 |
Vienna Globa.. | 102.60 | ![]() |
0 |
Düsseldorf | 102.50 | ![]() |
0 |
Hannover | 104.30 | ![]() |
0 |
Berlin | 104.15 | ![]() |
0 |
SIX Swiss Ex.. | 102.20 | ![]() |
|
SIX Swiss Ex.. | 97.00 | ![]() |
|
gettex | 102.750 | ![]() |
|
Nasdaq Other.. | 112.3400 | 146 | |
EUREX | Options |
News
- Merck to acquire ArQule for $2.7B
12/09/2019 / 23:36 - TeleTrader - Vaccinex Reports Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 14:00 - GlobeNewswire - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11/09/2019 / 14:02 - GlobeNewswire - Merck says Q3 sales jump 12% YoY to $12.4B
10/29/2019 / 11:49 - TeleTrader - Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France
09/27/2019 / 12:05 - GlobeNewswire